What is Positive Predictive Value (PPV)?
Positive Predictive Value (PPV) assesses a diagnostic test’s accuracy by calculating the probability that a person who tests positive truly has the condition. PPV focuses on how trustworthy a positive result is in real-world testing scenarios. Hence, it is the best measure for interpreting an individual positive test result. Mammography, for example, is a well-known case where PPV plays a central role in understanding what a positive test result really means.
Conversely, if you are evaluating a test’s inherent accuracy, it’s better to use sensitivity and specificity because they are not affected by how common the condition is.
Positive Predictive Value is one of several measures calculated from a confusion matrix, which categorizes test results into four mutually exclusive outcomes: true positives (TP), false positives (FP), true negatives (TN), and false negatives (FN). PPV uses the counts of true positives and false positives to determine how often a positive test result truly indicates the presence of the condition.
For example, if a test has a 90% PPV, a positive test result indicates that the person has a 90% chance of actually having the condition.
In this post, learn more about positive predictive values, how to calculate and interpret them, how they compare to sensitivity, and understand the clinical ramifications of these values by assessing real mammogram accuracy results.
Learn more about the related measures of Sensitivity and Specificity and Negative Predictive Values.
Positive Predictive Value Formula
The positive predictive value formula is the following ratio:
This calculation finds the proportion of positive test results that are correct out of the entire pool of all positives, both true and false. The PPV incorporates the prevalence of the condition in the population by including the number of false positives in the formula. PPV tends to be higher when the condition is common because it reduces the false positive number in the denominator, thereby increasing the ratio’s value.
For example, imagine a disease screening test applied to 1,000 people, where 80 are truly diseased and test positive, while 40 disease-free individuals mistakenly test positive. The PPV would be:
This result indicates a 66.7% chance that a person with a positive result truly has the disease.
How Prevalence Affects Positive Predictive Value
Many people wonder: What does positive predictive value mean in the context of prevalence?
The key issue is that prevalence changes the mix of true and false positives.
When a condition is rare, even a test with good sensitivity can produce more false positives than true positives. This situation drives PPV down, meaning many positive results will be incorrect. Statisticians refer to this scenario as the false positive paradox, which I discuss and include a worked example in my post: Base Rate Fallacy: Overview & Examples.
When a condition is common, the number of true positives rises and false positives drops. This circumstance boosts PPV, making positive results more reliable.
Positive predictive value incorporates prevalence by including true positives + false positives in the denominator. The prevalence of the disease changes how many people are at risk of being in those two categories.
Contrast this with sensitivity:
Sensitivity only considers people who truly have the disease, so prevalence does not affect it. It’s a best-case scenario for testing accuracy and provides a level playing field to compare tests.
Positive Predictive Value vs. Sensitivity
Both measures are helpful, but they answer different questions.
- Positive Predictive Value tells you the reliability of a positive test result. It is patient-centered and most helpful for interpreting an individual’s result.
- Sensitivity tells you how good the test is at detecting disease in those who actually have it. It is test-centered and helps evaluate the test’s inherent ability. Use this measure to determine which of several related tests is best.
| Measure | Strengths | Weaknesses |
| PPV | Directly interprets what a positive test result means for a patient; incorporates real-world prevalence. | Does not compare the reliability of multiple tests on a level playing field. |
| Sensitivity | Intrinsic to the test, independent of prevalence; useful for evaluating the test’s capability. | Does not tell you the probability that a positive result is correct; can appear strong even when PPV is low for rare conditions. |
Practical implications:
- Positive predictive value helps you understand what a positive test result means for an individual. For example, if a test has a PPV of 80%, you can tell a patient that 8 out of 10 people with a positive result truly have the condition.
- Sensitivity helps you evaluate and compare tests. For example, if two COVID-19 screening tests have 70% and 95% sensitivities, you know the second one will miss far fewer true cases, making it the better choice in most contexts.
Example Scenario: Interpreting Sensitivity and PPV
Mammography is a well-studied test for breast cancer and illustrates the difference between sensitivity and positive predictive value.
Mammograms typically have a sensitivity in the 80–90% range, depending on the population. They are more accurate in older women and those with less dense breast tissue, and somewhat less sensitive in younger women with denser breasts. This sensitivity means that mammography detects 8 or 9 out of every 10 cancers when they are present. That reflects the test’s inherent ability to identify cancer.
However, the positive predictive value is far more volatile because it depends strongly on prevalence. In population-wide screening where most women do not have breast cancer, PPV can be quite low. For example, some studies report that only about 5–10% of women recalled for further testing after a screening mammogram actually have cancer. In that setting, the low prevalence makes false positives common, dragging PPV down.
By contrast, when mammography occurs in a diagnostic setting where suspicion is already higher (e.g., a woman has a palpable lump), the PPV rises substantially. In such cases, published studies often report PPV values around 60–70%. Here, the prevalence of disease in the tested group is higher, so a positive result is far more likely to indicate cancer.
Interpretation
- The sensitivity of 80–90% reflects mammography’s inherent ability to detect most cancers when present. That information helps in evaluating the test itself.
- The positive predictive value—low in general screening but much higher in diagnostic contexts—shows what a positive mammogram means for an individual patient. In screening, a positive result often does not mean cancer, while a positive result is more trustworthy in diagnostic use.
This real-world example highlights why you must consider both sensitivity and PPV. Sensitivity tells you the test is effective at catching disease when it’s present, but PPV reveals that many positive results are misleading in a low-prevalence setting.
Clinical Decision Implications
For common diseases, a high positive predictive value means clinicians can act with confidence on positive results. For rare diseases, even accurate tests may yield low PPV, so confirmatory testing is often required. This practice avoids unnecessary treatment caused by false positives.
Clinicians, researchers, and policymakers should use PPV when interpreting test results for individual patients and sensitivity when evaluating how well a test performs in detecting disease overall.
Key Takeaways
- Positive Predictive Value meaning: the probability that a positive test result for an individual is correct.
- PPV depends heavily on disease prevalence; sensitivity does not.
- Use sensitivity to measure a test’s capability and to compare it to other tests; use PPV to interpret what a positive result means for a patient.
- In low-prevalence settings, PPV can be low even when sensitivity is high, so confirmatory testing is often needed.
References
-
Halladay JR, Yankaskas BC, Bowling JM, Alexander C. Positive Predictive Value of Mammography: Comparison of Interpretations of Screening and Diagnostic Images by the Same Radiologist and by Different Radiologists. AJR American Journal of Roentgenology. 2010;195(3):782-785. doi:10.2214/AJR.09.2955.
-
Mello JMRB, Bittelbrunn FP, Rockenbach MABC, et al. Breast cancer mammographic diagnosis performance in a public health institution: a retrospective cohort study. Insights into Imaging. 2017;8(6):581-588. doi:10.1007/s13244-017-0573-2.
-
National Cancer Institute. Breast Cancer Screening (PDQ®)–Health Professional Version. Updated April 10, 2025.




Comments and Questions